08/21/2026
Hadassah is for multiple myeloma patients!
He had bought a ticket to Switzerland to end his suffering. Then Hadassah gave him a reason to tear it up.
For years, this man with multiple myeloma endured debilitating pain and severe itching. Conventional treatments had failed, and relief seemed out of reach.
But Dr. Yuval Tal, director of the Allergy and Clinical Immunology Unit at Hadassah Hospital Ein Kerem, saw another possibility.
“The failure of standard treatments did not mean that all options had been exhausted.”
Dr. Tal and his team looked beyond the usual treatments and focused on the biological mechanisms behind the patient’s symptoms. Their approach led to an unexpected treatment: omalizumab, an antibody therapy typically used for severe allergies and asthma.
Within weeks of three injections, the patient’s pain and itching improved dramatically. He was able to reduce many of his pain medications — and most remarkably, he tore up his ticket to Switzerland.
A treatment that began with a question became a new reason for hope.
At Hadassah, when one path ends, our doctors keep looking for another.
Tap the link in the comment section to read the full story.
